无针注射对四种常见猪用疫苗免疫效果的评估
本研究评估了无针注射(NFI)与针头注射(NI)在猪中接种两种活疫苗(CSFV和PRRSV)和两种灭活疫苗(PCV和FMDV)的效果。结果显示,在0.5和0.8免疫剂量下,NFI组CSFV和PRRSV平均抗体水平及抗体转化率均高于NI组;FMDV疫苗NFI组抗体水平及转化率低于NI组;PCV疫苗在相同剂量下NFI组抗体产生高于NI组。总体上NFI未显著影响体温和增重等生理参数,对四种疫苗中的三种显示出与NI相当或更优的免疫原性。
要点
- NFI接种CSFV和PRRSV活疫苗在0.5和0.8剂量下抗体水平及转化率均高于NI。
- NFI接种FMDV灭活疫苗抗体水平及转化率低于NI,而PCV疫苗NFI抗体产生高于NI。
- NFI未显著影响猪体温和增重等生理参数。
核心结论
- NFI对四种疫苗中的三种(CSFV、PRRSV、PCV)显示出与NI相当或更优的免疫原性。
研究设计与样本
- 本研究在猪中比较了NFI与NI接种两种活疫苗(CSFV和PRRSV)和两种灭活疫苗(PCV和FMDV)的效果。
主要发现
- 在0.5和0.8免疫剂量下,NFI组CSFV和PRRSV平均抗体水平均高于NI组,且两个剂量下NFI组抗体转化率均更高。
- FMDV疫苗NFI组抗体水平低于NI组,NFI组抗体转化率也更低。
- 相同剂量下PCV疫苗NFI组抗体产生高于NI组。
- NFI未显著影响体温和增重等生理参数。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
With increasing concerns about food safety and animal welfare, as well as to support the development of large-scale and intensive animal husbandry, needle-free injection (NFI) technology has been widely used in vaccination and drug treatment. Therefore, this study evaluated the effects of two live vaccines (CSFV and PRRSV) and two inactivated vaccines (PCV and FMDV) delivered by NFI and needle injection (NI) in pigs. The average CSFV and PRRSV antibody levels in pigs were higher for NFI than for NI at immunization doses of 0.5 and 0.8, and the antibody conversion rate was higher for NFI at both doses. Regarding inactivated vaccines, the antibody level for FMDV was lower for NFI than for NI, and NFI was also linked to a lower antibody conversion rate. Conversely, antibody production following vaccination with PCV was higher for NFI than for NI at the same dose. In general, NFI did not significantly affect physiological parameters, such as body temperature and weight gain. Concerning the immunization effect, NFI showed comparable or superior immunogenicity for three of the four than NI. This study provides technical support and reference for the use and promotion of novel immunization modalities.
引用
- Wu Y, Ren B, Gao X, et al. Evaluation of the immunization effects of needle-free injection for four common porcine vaccines. Vaccine. 2025. PMID: 41192045. doi:10.1016/j.vaccine.2025.127943
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。